Due to COVID-Related Travel Restrictions, Required Inspection of the Revance Manufacturing Site by the U.S. Food and Drug Administration (FDA) has Not Been Scheduled.
I.e., the FDA has not formally delayed the PDUFA date, but it’s unlikely that the required manufacturing inspection will be done between now and 11/25/20 PDUFA date.